RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection

European Journal of Cardio-thoracic Surgery

Volumn 48, Issue 5, 2015, Pages 732-737

  Cabrera Fuentes, Hector A ^a,b   Niemann, Bernd ^a   Grieshaber, Philippe ^a   Wollbrueck, Matthias ^a   Gehron, Johannes ^a   Preissner, Klaus T ^a,b   Böning, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Acute inflammation; Cardiac surgery; Extracellular RNA (eRNA); Ischaemia reperfusion; Remote ischaemic preconditioning; Ribonuclease 1 (RNase1); Tumour necrosis factor (TNF )

Indexed keywords

EXTRACELLULAR RNA; RIBONUCLEASE; RIBONUCLEASE 1; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; CYTOKINE PRODUCTION; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; ISCHEMIC PRECONDITIONING; PRIORITY JOURNAL; RADIAL ARTERY; REMOTE ISCHEMIC PRECONDITIONING; REPERFUSION INJURY; AGED; BLOOD; CHEMISTRY; EXTRACELLULAR SPACE; HEART INFARCTION PREVENTION; MALE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOTONIC AGENTS; EXTRACELLULAR SPACE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPERFUSION INJURY; RIBONUCLEASES; RNA;

EID: 84942995150     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu519     Document Type: Article

References (21)

1. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575-9.
2. ThielmannM, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013;382:597-604.
3. Candilio L, Malik A, Ariti C, Barnard M, Di Salvo C, Lawrence D et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart 2014; doi: 10.1136/heartjnl-2014-306178.
4. Fischer S, Cabrera-Fuentes HA, Noll T, Preissner KT. Impact of extracellular RNA on endothelial barrier function. Cell Tissue Res 2014;355:635-45.
5. Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S, Kostin S, Inserte J, Saffarzadeh M et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-alpha in cardiac ischaemia/reperfusion injury. Thromb Haemost 2014;112:1110-9.
6. Simsekyilmaz S, Cabrera-Fuentes HA, Meiler S, Kostin S, Baumer Y, Liehn EA et al. Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation 2014;129:598-606.
7. Simsekyilmaz S, Cabrera-Fuentes HA, Meiler S, Kostin S, Baumer Y, Liehn EA et al. Response to letter regarding article "role of extracellular RNA in atherosclerotic plaque formation in mice". Circulation 2014;130:e144-5.
8. Fischer S, Nishio M, Dadkhahi S, Gansler J, Saffarzadeh M, Shibamiyama A et al. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb Haemost 2011;105:345-55.
9. Landre JB, Hewett PW, Olivot JM, Friedl P, Ko Y, Sachinidis A et al. Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1). J Cell Biochem 2002;86:540-52.
10. Moenner M, Hatzi E, Badet J. Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions. In Vitro Cell Dev Biol Anim 1997;33:553-61.
11. Gaur D, Swaminathan S, Batra JK. Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitorresistant cytotoxic variants. J Biol Chem 2001;276:24978-84.
12. Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007;104:6388-93.
13. Fischer S, Nishio M, Peters SC, Tschernatsch M, Walberer M, Weidemann S et al. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J 2009;23:2100-9.
14. Walberer M, Tschernatsch M, Fischer S, Ritschel N, Volk K, Friedrich C et al. RNase therapy assessed by magnetic resonance imaging reduces cerebral edema and infarction size in acute stroke. Curr Neurovasc Res 2009;6:12-9.
15. Wan S, DeSmet JM, Barvais L, GoldsteinM, Vincent JL, LeClerc JL.Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:806-11.
16. Donndorf P, Kuhn F, Vollmar B, Rosner J, Liebold A, Gierer P et al. Comparing microvascular alterations during minimal extracorporeal circulation and conventional cardiopulmonary bypass in coronary artery bypass graft surgery: a prospective, randomized study. J Thorac Cardiovasc Surg 2012;144:677-83.
17. Liebold A, Langhammer T, Brunger F, Birnbaum DE. Cardiac interleukin-6 release and myocardial recovery after aortic crossclamping. Crystalloid versus blood cardioplegia. J Thorac Cardiovasc Surg 1999;40:633-6.
18. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-75.
19. Ovize M, Thibault H, Przyklenk K. Myocardial conditioning: opportunities for clinical translation. Circ Res 2013;113:439-50.
20. Meybohm P, Zacharowski K, Cremer J, Roesner J, Kletzin F, Schaelte G et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial-the RIPHeart-Study. Eur Heart J 2012;33:1423-6.
21. Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol 2012;101:339-48.